1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar : PubMed/NCBI
|
2
|
Lazar V, Suo C, Orear C, van den Oord J,
Balogh Z, Guegan J, Job B, Meurice G, Ripoche H, Calza S, et al:
Integrated molecular portrait of non-small cell lung cancers. BMC
Med Genomics. 6:532013. View Article : Google Scholar : PubMed/NCBI
|
3
|
Devesa SS, Bray F, Vizcaino AP and Parkin
DM: International lung cancer trends by histologic type:
Male:female differences diminishing and adenocarcinoma rates
rising. Int J Cancer. 117:294–299. 2005. View Article : Google Scholar : PubMed/NCBI
|
4
|
Borczuk AC, Qian F, Kazeros A, Eleazar J,
Assaad A, Sonett JR, Ginsburg M, Gorenstein L and Powell CA:
Invasive size is an independent predictor of survival in pulmonary
adenocarcinoma. Am J Surg Pathol. 33:462–469. 2009. View Article : Google Scholar : PubMed/NCBI
|
5
|
van Rens MT, de la Rivière AB, Elbers HR
and van Den Bosch JM: Prognostic assessment of 2,361 patients who
underwent pulmonary resection for non-small cell lung cancer, stage
I, II and IIIA. Chest. 117:374–379. 2000. View Article : Google Scholar : PubMed/NCBI
|
6
|
Sakurai H, Maeshima A, Watanabe S, Suzuki
K, Tsuchiya R, Maeshima AM, Matsuno Y and Asamura H: Grade of
stromal invasion in small adenocarcinoma of the lung:
Histopathological minimal invasion and prognosis. Am J Surg Pathol.
28:198–206. 2004. View Article : Google Scholar : PubMed/NCBI
|
7
|
Veiseh O, Kievit FM, Ellenbogen RG and
Zhang M: Cancer cell invasion: Treatment and monitoring
opportunities in nanomedicine. Adv Drug Deliv Rev. 63:582–596.
2011. View Article : Google Scholar : PubMed/NCBI
|
8
|
Kam Y, Rejniak KA and Anderson AR:
Cellular modeling of cancer invasion: Integration of in silico and
in vitro approaches. J Cell Physiol. 227:431–438. 2012. View Article : Google Scholar : PubMed/NCBI
|
9
|
Freije JM, Balbin M, Pendás AM, Sánchez
LM, Puente XS and López-Otin C: Matrix metalloproteinases and tumor
progression. Adv Exp Med Biol. 532:91–107. 2003. View Article : Google Scholar : PubMed/NCBI
|
10
|
Kleiner DE and Stetler-Stevenson WG:
Matrix metalloproteinases and metastasis. Cancer Chemother
Pharmacol. 43 Suppl:S42–S51. 1999. View Article : Google Scholar : PubMed/NCBI
|
11
|
Kumaki F, Matsui K, Kawai T, Ozeki Y, Yu
ZX, Ferrans VJ and Travis WD: Expression of matrix
metalloproteinases in invasive pulmonary adenocarcinoma with
bronchioloalveolar component and atypical adenomatous hyperplasia.
Am J Pathol. 159:2125–2135. 2001. View Article : Google Scholar : PubMed/NCBI
|
12
|
Chen CK, Chen PR, Huang HC, Lin YS and
Fang HY: Overexpression of matrix metalloproteinases in lung tissue
of patients with primary spontaneous pneumothorax. Respiration.
88:418–425. 2014. View Article : Google Scholar : PubMed/NCBI
|
13
|
Sun Y, Wang L, Jiang M, Huang J, Liu Z and
Wolfl S: Secreted phosphoprotein 1 upstream invasive network
construction and analysis of lung adenocarcinoma compared with
human normal adjacent tissues by integrative biocomputation. Cell
Biochem Biophys. 56:59–71. 2010. View Article : Google Scholar : PubMed/NCBI
|
14
|
Yan KH, Lee LM, Yan SH, Huang HC, Li CC,
Lin HT and Chen PS: Tomatidine inhibits invasion of human lung
adenocarcinoma cell A549 by reducing matrix metalloproteinases
expression. Chem Biol Interact. 203:580–587. 2013. View Article : Google Scholar : PubMed/NCBI
|
15
|
Kao SJ, Su JL, Chen CK, Yu MC, Bai KJ,
Chang JH, Bien MY, Yang SF and Chien MH: Osthole inhibits the
invasive ability of human lung adenocarcinoma cells via suppression
of NF-κB-mediated matrix metalloproteinase-9 expression. Toxicol
Appl Pharmacol. 261:105–115. 2012. View Article : Google Scholar : PubMed/NCBI
|
16
|
Falcone D, Gallelli L, Di Virgilio A,
Tucci L, Scaramuzzino M, Terracciano R, Pelaia G and Savino R:
Effects of simvastatin and rosuvastatin on RAS protein, matrix
metalloproteinases and NF-κB in lung cancer and in normal pulmonary
tissues. Cell Prolif. 46:172–182. 2013. View Article : Google Scholar : PubMed/NCBI
|
17
|
Storz P, Döppler H, Copland JA, Simpson KJ
and Toker A: FOXO3a promotes tumor cell invasion through the
induction of matrix metalloproteinases. Mol Cell Biol.
29:4906–4917. 2009. View Article : Google Scholar : PubMed/NCBI
|
18
|
Assembly WMAG: World medical association
declaration of Helsinki: Ethical principles for medical research
involving human subjects. Chinese J Integrative Med. 310:2191–2194.
2001.
|
19
|
Stearman RS, Dwyer-Nield L, Zerbe L,
Blaine SA, Chan Z, Bunn PA Jr, Johnson GL, Hirsch FR, Merrick DT,
Franklin WA, et al: Analysis of orthologous gene expression between
human pulmonary adenocarcinoma and a carcinogen-induced murine
model. Am J Pathol. 167:1763–1775. 2005. View Article : Google Scholar : PubMed/NCBI
|
20
|
Gautier L, Cope L, Bolstad BM and Irizarry
RA: Affy-analysis of Affymetrix GeneChip data at the probe level.
Bioinformatics. 20:307–315. 2004. View Article : Google Scholar : PubMed/NCBI
|
21
|
Ritchie ME, Phipson B, Wu D, Hu Y, Law CW,
Shi W and Smyth GK: limma powers differential expression analyses
for RNA-sequencing and microarray studies. Nucleic Acids Res.
43:e472015. View Article : Google Scholar : PubMed/NCBI
|
22
|
Na S, Xumin L and Yong G: Research on
k-means clustering algorithm: An improved k-means clustering
algorithmProceedings of the Third International Symposium on
Intelligent Information Technology and Security Informatics
(IITSI). IITSI; Jian: pp. 63S–67S. 2010, View Article : Google Scholar
|
23
|
Månsson R, Tsapogas P, Akerlund M,
Lagergren A, Gisler R and Sigvardsson M: Pearson correlation
analysis of microarray data allows for the identification of
genetic targets for early B-cell factor. J Biol Chem.
279:17905–17913. 2004. View Article : Google Scholar : PubMed/NCBI
|
24
|
Sherlock G: Gene Ontology: Tool for the
unification of biology. Canadian Institute Food Sci Technol J.
22:4152009.
|
25
|
Kanehisa M, Sato Y, Kawashima M, Furumichi
M and Tanabe M: KEGG as a reference resource for gene and protein
annotation. Nucleic Acids Res. 44:D457–D462. 2016. View Article : Google Scholar : PubMed/NCBI
|
26
|
da Huang W, Sherman BT and Lempicki RA:
Systematic and integrative analysis of large gene lists using DAVID
bioinformatics resources. Nature Protoc. 4:44–57. 2009. View Article : Google Scholar
|
27
|
Benjamini Y and Hochberg Y: Controlling
the false discovery rate: A practical and powerful approach to
multiple testing. J Royal Statistical Society. 57:289–300.
1995.
|
28
|
Yeung N, Cline MS, Kuchinsky A, Smoot ME
and Bader GD: Exploring biological networks with Cytoscape
software. Curr Protoc Bioinformatics. 23Chapter 8. (8.13):
8.13.1–8.13.20. 2008. View Article : Google Scholar
|
29
|
Fanjul-Fernández M, Folgueras AR, Fueyo A,
Balbín M, Suárez MF, Fernández-García MS, Shapiro SD, Freije JM and
López-Otín C: Matrix metalloproteinase Mmp-1a is dispensable for
normal growth and fertility in mice and promotes lung cancer
progression by modulating inflammatory responses. J Biol Chem.
288:14647–14656. 2013. View Article : Google Scholar : PubMed/NCBI
|
30
|
Yang B, Gao J, Rao Z, Zhang B, Ouyang W
and Yang C: Antisense oligonucleotide targeting matrix
metalloproteinase-7 (MMP-7) changes the ultrastructure of human
A549 lung adenocarcinoma cells. Ultrastruct Pathol. 35:256–259.
2011. View Article : Google Scholar : PubMed/NCBI
|
31
|
Bartling B, Rehbein G, Schmitt WD, Hofmann
H-S, Silber R-E and Simm A: S100A2–S100P expression profile and
diagnosis of non-small cell lung carcinoma: impairment by advanced
tumour stages and neoadjuvant chemotherapy. Eur J Cancer.
43:1935–1943. 2007. View Article : Google Scholar : PubMed/NCBI
|
32
|
Hung WC, Tseng WL, Shiea J and Chang HC:
Skp2 overexpression increases the expression of MMP-2 and MMP-9 and
invasion of lung cancer cells. Cancer Lett. 288:156–161. 2010.
View Article : Google Scholar : PubMed/NCBI
|
33
|
Sauter W, Rosenberger A, Beckmann L, Kropp
S, Mittelstrass K, Timofeeva M, Wölke G, Steinwachs A, Scheiner D,
Meese E, et al: Matrix metalloproteinase 1 (MMP1) is associated
with early-onset lung cancer. Cancer Epidemiol Biomarkers Prev.
17:1127–1135. 2008. View Article : Google Scholar : PubMed/NCBI
|
34
|
Soon WW, Miller LD, Black MA, Dalmasso C,
Chan XB, Pang B, Ong CW, SaltoTellez M, Desai KV and Liu ET:
Combined genomic and phenotype screening reveals secretory factor
SPINK1 as an invasion and survival factor associated with patient
prognosis in breast cancer. EMBO Mol Med. 3:451–464. 2011.
View Article : Google Scholar : PubMed/NCBI
|
35
|
Sunaga N, Kohno T, Yanagitani N, Sugimura
H, Kunitoh H, Tamura T, Takei Y, Tsuchiya S, Saito R and Yokota J:
Contribution of the NQO1 and GSTT1 polymorphisms to lung
adenocarcinoma susceptibility. Cancer Epidemiol Biomarkers Prev.
11:730–738. 2002.PubMed/NCBI
|
36
|
Chao C, Zhang ZF, Berthiller J, Boffetta P
and Hashibe M: NAD(P)H:quinone oxidoreductase 1 (NQO1) Pro187Ser
polymorphism and the risk of lung, bladder, and colorectal cancers:
A meta-analysis. Cancer Epidemiol Biomarkers Prev. 15:979–987.
2006. View Article : Google Scholar : PubMed/NCBI
|
37
|
Du M, Wang G, Barraclough R and Rudland P:
P0017 S100P regulates cytoskeleton dynamics to promote cell
migration and metastasis. Eur J Cancer. 51:e6–e7. 2015. View Article : Google Scholar
|
38
|
Whiteman HJ, Weeks ME, Dowen SE, Barry S,
Timms JF, Lemoine NR and Crnogorac-Jurcevic T: The role of S100P in
the invasion of pancreatic cancer cells is mediated through
cytoskeletal changes and regulation of cathepsin D. Cancer Res.
67:8633–8642. 2007. View Article : Google Scholar : PubMed/NCBI
|
39
|
Agarwal R, D'Souza T and Morin PJ:
Claudin-3 and claudin-4 expression in ovarian epithelial cells
enhances invasion and is associated with increased matrix
metalloproteinase-2 activity. Cancer Res. 65:7378–7385. 2005.
View Article : Google Scholar : PubMed/NCBI
|
40
|
Ateeq B, Tomlins SA, Laxman B, Asangani
IA, Cao Q, Cao X, Li Y, Wang X, Feng FY, Pienta KJ, et al:
Therapeutic targeting of SPINK1-positive prostate cancer. Sci
Transl Med. 3:72ra172011. View Article : Google Scholar : PubMed/NCBI
|
41
|
Lee CG, Ren J, Cheong IS, Ban KH, Ooi LL,
Tan Yong S, Kan A, Nuchprayoon I, Jin R, Lee KH, et al: Expression
of the FAT10 gene is highly upregulated in hepatocellular carcinoma
and other gastrointestinal and gynecological cancers. Oncogene.
22:2592–2603. 2003. View Article : Google Scholar : PubMed/NCBI
|
42
|
Yan DW, Li DW, Yang YX, Xia J, Wang XL,
Zhou CZ, Fan JW, Wen YG, Sun HC, Wang Q, et al: Ubiquitin D is
correlated with colon cancer progression and predicts recurrence
for stage II-III disease after curative surgery. Br J Cancer.
103:961–969. 2010. View Article : Google Scholar : PubMed/NCBI
|
43
|
Kim H, Watkinson J, Varadan V and
Anastassiou D: Multi-cancer computational analysis reveals
invasion-associated variant of desmoplastic reaction involving
INHBA, THBS2 and COL11A1. BMC Med Genomics. 3:512010. View Article : Google Scholar : PubMed/NCBI
|
44
|
Li J, Tu Y, Jiang L, Xu H and Zhang S:
Expression and significance of Snail and Claudin-3 in non-small
cell lung cancer. Zhongguo Fei Ai Za Zhi. 15:583–590. 2012.(In
Chinese). PubMed/NCBI
|
45
|
Yang L, Chen Y, Cui T, Knösel T, Zhang Q,
Albring KF, Huber O and Petersen I: Desmoplakin acts as a tumor
suppressor by inhibition of the Wnt/β-catenin signaling pathway in
human lung cancer. Carcinogenesis. 33:1863–1870. 2012. View Article : Google Scholar : PubMed/NCBI
|
46
|
Lin CY, Tsai PH, Kandaswami CC, Lee PP,
Huang CJ, Hwang JJ and Lee MT: Matrix metalloproteinase-9
cooperates with transcription factor Snail to induce
epithelial-mesenchymal transition. Cancer Sci. 102:815–827. 2011.
View Article : Google Scholar : PubMed/NCBI
|
47
|
Nerlov C: The C/EBP family of
transcription factors: A paradigm for interaction between gene
expression and proliferation control. Trends Cell Biol. 17:318–324.
2007. View Article : Google Scholar : PubMed/NCBI
|
48
|
Armstrong DA, Phelps LN and Vincenti MP:
CCAAT enhancer binding protein-beta regulates matrix
metalloproteinase-1 expression in interleukin-1beta-stimulated A549
lung carcinoma cells. Mol Cancer Res. 7:1517–1524. 2009. View Article : Google Scholar : PubMed/NCBI
|